Brookings March 10, 2020
Michael E. Chernew, Leemore Dafny, and Maximilian Pany

THE PROBLEM

The United States spends a larger share of its GDP on health care than any other advanced economy. The high private sector health-care spending in the United States relative to that of other economies is driven largely by higher prices. However, there is scant evidence that high U.S. provider prices reflect better quality of care. Because market forces have not yielded competitive commercial provider prices, the authors believe policy intervention is necessary.

THE PROPOSAL

Although the United States will likely continue to rely on markets to allocate most health-care resources, market competition has not been sufficient to control commercial provider prices. In this proposal, Michael Chernew, Leemore Dafny, and Maximilian Pany discuss how price regulations could be used...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pricing / Spending, Provider
Beware of Contemporary Health Spending Trends: Prepare for Change
Price transparency divides hospitals, CMS
How Can Employers Manage Rising Healthcare Costs in 2025?
The 17 hospitals fined for price transparency violations, by state
STAT+: Latest updates to hospital price transparency rules aim to make the data more useful

Share This Article